NCBI highlights that H3N2 flu increases vulnerability to secondary infections such as pneumonia and bronchitis. Complications are more common in elderly patients and those with comorbidities. Monitoring persistent fever, dyspnea, or worsening symptoms ensures earlier intervention. Antiviral therapy and supportive care remain essential to reduce progression and improve clinical outcomes.